Verified employee & interview reviews

Zydus Lifesciences Reviews

Ahmedabad, Gujarat

—/ 5

0 reviews

Zydus Lifesciences Limited, formerly known as Cadila Healthcare Limited, is a leading Indian multinational pharmaceutical company headquartered in Ahmedabad, Gujarat. Founded in 1952 by Mr. Ramanbhai B. Patel, the company has evolved from a local manufacturer into a fully integrated, global healthcare provider. It ranks as the 4th largest player in the Indian pharmaceutical industry and maintains a significant international presence, particularly in the United States, Europe, Latin America, and emerging markets. The company operates through two primary segments: Pharmaceuticals and Consumer Products. Its diverse portfolio includes active pharmaceutical ingredients (APIs), generic drugs, biosimilars, vaccines, and specialty formulations. Zydus is well-known for its innovation-led approach, exemplified by the launch of Lipaglyn for diabetic dyslipidemia and Exemptia, the world's first adalimumab biosimilar. Its manufacturing infrastructure is extensive, with 37 sites across India, Brazil, the UK, and the US, supported by a workforce of over 26,000 employees, including 1,400 scientists dedicated to research and development. In the consumer wellness space, Zydus holds market-leading positions through its subsidiary, Zydus Wellness. Notable brands under this umbrella include Sugar Free, which holds approximately 96% market share, Glucon-D, Nycil, Everyuth, and Complan. This segment focuses on personal care, food, and nutrition, contributing significantly to the group's overall revenue and brand recognition. Financially, Zydus Lifesciences is a robust performer, publicly traded on the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE). For the fiscal year 2025, the company reported a consolidated revenue of approximately INR 23,241 crore. The leadership team, headed by Chairman Pankaj R. Patel and Managing Director Dr. Sharvil P. Patel, emphasizes a culture of "Zydus First," focusing on excellence in execution and path-breaking discoveries to address unmet healthcare needs. Beyond business operations, the group is deeply committed to sustainability and social responsibility through its "Zydus Srishti" program. This initiative focuses on healthcare, education, and community outreach. The company has received numerous accolades, including the "India Pharma Excellence Award" and recognition as a "Great Place to Work." With a legacy spanning over seven decades, Zydus Lifesciences continues to advance its mission of creating healthier, happier communities globally by unlocking new possibilities in life sciences.